Refine
Year of publication
Document Type
- Article (105)
- Postprint (22)
- Conference Proceeding (3)
- Review (2)
- Other (1)
Is part of the Bibliography
- yes (133)
Keywords
- zinc (7)
- Arsenolipids (6)
- Caenorhabditis elegans (6)
- manganese (6)
- Arsenic-containing hydrocarbons (5)
- Boron exposure (5)
- C. elegans (5)
- Arsenic-containing fatty acids (4)
- Boric acid (4)
- DNA damage (4)
- DNA damage response (4)
- Manganese (4)
- Methylmercury (4)
- Toxicity (4)
- Zinc (4)
- arsenolipids present (4)
- cells (4)
- cod-liver (4)
- copper (4)
- electrochemistry (4)
- fatty-acids (4)
- homeostasis (4)
- identification (4)
- neurodegenerative diseases (4)
- neurotoxicity (4)
- Astrocytes (3)
- DNA repair (3)
- Development (3)
- Metabolism (3)
- Modified mycotoxins (3)
- Neurotoxicity (3)
- methylmercury (3)
- oxidative stress (3)
- selenium (3)
- transformation products (3)
- 2D-LC-MS/MS (2)
- Apoptosis (2)
- Arsenic (2)
- Arsenic speciation (2)
- Biomarker (2)
- Caco-2 intestinal barrier model (2)
- Caco-2/HT-29-MTX-model (2)
- Cereals (2)
- Copper (2)
- Cytotoxicity (2)
- Dopamine (2)
- Foxp3 (2)
- GPx activity (2)
- Genotoxicity (2)
- HRMS (2)
- ICP-MS (2)
- In vitro blood-brain barrier model (2)
- LC/HRMS (2)
- Labile zinc (2)
- Mercuric mercury (2)
- Multi-method (2)
- Mycotoxins (2)
- Nrf2 (2)
- Oxidative stress (2)
- Parkinson disease (2)
- Pesticides (2)
- RP-HPLC (2)
- S-XRF (2)
- SIMS techniques (2)
- Se (2)
- Selenium (2)
- TEM (2)
- Thiomersal (2)
- Thioredoxin (2)
- Trace elements (2)
- Zinc homeostasis (2)
- Zinypr-1 (2)
- adduct formation (2)
- ageing (2)
- aging (2)
- base excision repair (incision activity) (2)
- binding (2)
- biomarker (2)
- bladder-cancer (2)
- c. elegans (2)
- carcinogen exposure (2)
- cardiovascular disease (2)
- cell-death (2)
- cellular bioimaging (2)
- coenzyme-a (2)
- copper-related disorders (2)
- cytosine methylation (2)
- database (2)
- disease (2)
- energy-metabolism (2)
- excision-repair (2)
- exposure (2)
- fish (2)
- fluorescent probe (2)
- force-field (2)
- free zinc (2)
- gene-expression (2)
- genomic dna methylation (2)
- glutathione (2)
- goblet cells (2)
- hallervorden-spatz-syndrome (2)
- human-cells (2)
- hydrolysis (2)
- in vitro intestinal model (2)
- induced malignant-transformation (2)
- intestinal mucins (2)
- intestinal zinc resorption (2)
- iron (2)
- life-span (2)
- liver (2)
- maintenance of genomic integrity (2)
- marine oils (2)
- mass-spectrometry (2)
- menadione (2)
- metabolites (2)
- methyltransferases dnmt3a (2)
- mobility-mass spectrometry (2)
- model (2)
- monensin (2)
- mucus layer (2)
- n-acetyl-cysteine (2)
- neurodegeneration (2)
- oil (2)
- poly(ADP-ribose) polymerase-1 (2)
- poly(ADP-ribosyl)ation (2)
- protein (2)
- repair (2)
- rp-hplc (2)
- s-glutathionylation (2)
- selenoprotein P (2)
- serum (2)
- sex (2)
- status markers (2)
- thimerosal (2)
- thio-dimethylarsinic acid (2)
- trivalent (2)
- veterinary drugs (2)
- vitro toxicological characterization (2)
- zinc binding (2)
- AMD (1)
- ARPE-19 cells (1)
- Advanced glycation end products (1)
- Age (1)
- Aging (1)
- Akt/PKB (1)
- Antioxidant (1)
- Arsenite (1)
- Arsenolipid (1)
- Arsenosugar (1)
- Automation (1)
- Beef (1)
- Beer (1)
- Biochemistry (1)
- Biological Sciences (1)
- Biological monitoring (1)
- Blood-cerebrospinal fluid barrier (1)
- Blood-liquor barrier (1)
- Books (1)
- C (1)
- Casein (1)
- Cell culture materials (1)
- Cellular bioavailability (1)
- Cellular damage response (1)
- Cognition (1)
- Collagen (1)
- Comet assay (1)
- Corylus avellana L. (1)
- Cu NP-incorporated MI-dPG coating (1)
- Cytokines (1)
- DAF-16 (1)
- DNA integrity (1)
- DNMT1 (1)
- Developmental toxicity (1)
- Dopaminergic neurons (1)
- ER stress (1)
- Elemental blood serum concentration (1)
- Experimental autoimmune encephalomyelitis (EAE) (1)
- FSH (1)
- Food (1)
- Freeze-fracturing (1)
- GADD45A and GADD45G (1)
- GC-MS (1)
- GSH (1)
- Gene expression (1)
- Global DNA methylation (1)
- Glyphosate (1)
- Human differentiated neurons (1)
- Human nutritional intervention (1)
- Hyphenated techniques (1)
- ICP-QQQ-MS (1)
- Inductively (1)
- Inductively coupled plasma mass spectrometry (1)
- Inert ingredients (1)
- Inflammation (1)
- Inorganic mercury (1)
- Isotope dilution analysis (1)
- Isotope ratios (1)
- Isotope-dilution analysis (1)
- Jod (1)
- Journals (1)
- LC (1)
- LC–MS/MS (1)
- LC−MS/MS (1)
- LH (1)
- LPS (1)
- Life science (1)
- Lipid (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Liquid-liquid extraction (1)
- Lithiumion battery (LIB) (1)
- Long-term cellular toxicity (1)
- Lupin (1)
- Macrophage-like phenotype (1)
- Male (1)
- Manganese . C. elegans (1)
- Membrane (1)
- Mercury (1)
- Metals (1)
- Methylglyoxal (1)
- Microbiome (1)
- Mitochondria (1)
- Mixed lymphocyte culture (MLC) (1)
- Motor coordination (1)
- Multi-mycotoxin analysis (1)
- Neurodegeneration (1)
- Neurodevelopmental toxicity (1)
- Neurons (1)
- Nif2 (1)
- Occurrence data (1)
- Oocytes (1)
- Organic arsenic (1)
- Organic carbonates (1)
- Organic mercury (1)
- Paternal exposure (1)
- Pericytes (1)
- Pig (1)
- Pregnancy outcomes (1)
- Presystemic metabolism (1)
- QuEChERS (1)
- ROS (1)
- Redox homeostasis (1)
- Regulatory T cells (Treg) (1)
- Reproduction (1)
- Reproductive toxicity (1)
- SGK-1 (1)
- Schilddrüse (1)
- Schilddrüsenautoimmunerkrankungen (1)
- Science and Mathematics (1)
- Se-methylselenoneine (1)
- Seafood (1)
- Selen (1)
- Selenoneine (1)
- Selenoproteine (1)
- Selenosugar 1 (1)
- Semen parameters (1)
- Serotonin (1)
- Sex (1)
- Sex ratio at birth (1)
- Signaling pathways (1)
- Small molecules (1)
- Small selenium species (1)
- Speciation (1)
- T helper 17 cells (1)
- Testosterone (1)
- Th17 (1)
- Thimerosal (1)
- Thio-arsenosugar-glycerol (1)
- Thio-dimethylarsinic acid (1)
- Thioredoxin reductase (1)
- ToF-SIMS (1)
- ToF-SIMS imaging (1)
- Total arsenic (1)
- Toxicokinetics (1)
- TraceAge (1)
- Transmembrane asymmetry (1)
- Tween40 micelles (1)
- Validation (1)
- Y:X chromosome ratio (1)
- antibacterial effect (1)
- antioxidant defense systems (1)
- bioavailability (1)
- caenorhabditis elegans (1)
- cereals (1)
- coupled plasma mass spectrometry (1)
- drug-resistant bacteria (1)
- elegans (1)
- hazelnut cultivars (1)
- healthy subjects (1)
- high-resolution imaging (1)
- human liver microsomes (1)
- in situ chemical reduction (1)
- in vitro blood-brain barrier model (1)
- inorganic mercury (1)
- ion chromatography (1)
- ion quantification (1)
- ionophore antibiotics (1)
- lipid analysis (1)
- lutein (1)
- membrane analysis (1)
- mercuric mercury (1)
- metabolic response (1)
- method development (1)
- method validation (1)
- minerals (1)
- modified mycotoxins (1)
- moxidectin (1)
- multi-mycotoxin analysis (1)
- nutrient composition (1)
- organic mercury (1)
- photochemistry (1)
- postprandial study (1)
- presystemic metabolism (1)
- qPCR-based gene expression screening (1)
- rapeseed protein (1)
- rat (1)
- regulatory T cells (1)
- salinomycin (1)
- sample preparation (1)
- selenoneine (1)
- selenoproteins (1)
- sodium (1)
- soy protein (1)
- thiomersal (1)
- tocopherols (1)
- transformation product (1)
- universal coating (1)
- validation (1)
- veterinary drug (1)
- yield enhancement (1)
While the underlying mechanisms of Parkinson’s disease (PD) are still insufficiently studied, a complex interaction between genetic and environmental factors is emphasized. Nevertheless, the role of the essential trace element zinc (Zn) in this regard remains controversial. In this study we altered Zn balance within PD models of the versatile model organism Caenorhabditis elegans (C. elegans) in order to examine whether a genetic predisposition in selected genes with relevance for PD affects Zn homeostasis. Protein-bound and labile Zn species act in various areas, such as enzymatic catalysis, protein stabilization pathways and cell signaling. Therefore, total Zn and labile Zn were quantitatively determined in living nematodes as individual biomarkers of Zn uptake and bioavailability with inductively coupled plasma tandem mass spectrometry (ICP-MS/MS) or a multi-well method using the fluorescent probe ZinPyr-1. Young and middle-aged deletion mutants of catp-6 and pdr-1, which are orthologues of mammalian ATP13A2 (PARK9) and parkin (PARK2), showed altered Zn homeostasis following Zn exposure compared to wildtype worms. Furthermore, age-specific differences in Zn uptake were observed in wildtype worms for total as well as labile Zn species. These data emphasize the importance of differentiation between Zn species as meaningful biomarkers of Zn uptake as well as the need for further studies investigating the role of dysregulated Zn homeostasis in the etiology of PD.
Inorganic arsenicals are environmental toxins that have been connected with neuropathies and impaired cognitive functions. To investigate whether such substances accumulate in brain astrocytes and affect their viability and glutathione metabolism, we have exposed cultured primary astrocytes to arsenite or arsenate. Both arsenicals compromised the cell viability of astrocytes in a time- and concentration-dependent manner. However, the early onset of cell toxicity in arsenite-treated astrocytes revealed the higher toxic potential of arsenite compared with arsenate. The concentrations of arsenite and arsenate that caused within 24 h half-maximal release of the cytosolic enzyme lactate dehydrogenase were around 0.3 mM and 10 mM, respectively. The cellular arsenic contents of astrocytes increased rapidly upon exposure to arsenite or arsenate and reached after 4 h of incubation almost constant steady state levels. These levels were about 3-times higher in astrocytes that had been exposed to a given concentration of arsenite compared with the respective arsenate condition. Analysis of the intracellular arsenic species revealed that almost exclusively arsenite was present in viable astrocytes that had been exposed to either arsenate or arsenite. The emerging toxicity of arsenite 4 h after exposure was accompanied by a loss in cellular total glutathione and by an increase in the cellular glutathione disulfide content. These data suggest that the high arsenite content of astrocytes that had been exposed to inorganic arsenicals causes an increase in the ratio of glutathione disulfide to glutathione which contributes to the toxic potential of these substances.
Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.
Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.
Treatment of caenorhabditis elegans with small selenium species enhances antioxidant defense systems
(2019)
ScopeSmall selenium (Se) species play a key role in Se metabolism and act as dietary sources of the essential trace element. However, they are redox-active and trigger pro- and antioxidant responses. As health outcomes are strongly species-dependent, species-specific characteristics of Se compounds are tested in vivo. Methods and resultsIn the model organism Caenorhabditis elegans (C. elegans), immediate and sustained effects of selenite, selenomethionine (SeMet), and Se-methylselenocysteine (MeSeCys) are studied regarding their bioavailability, incorporation into proteins, as well as modulation of the cellular redox status. While all tested Se compounds are bioavailable, only SeMet persistently accumulates and is non-specifically incorporated into proteins. However, the protection toward chemically-induced formation of reactive species is independent of the applied Se compound. Increased thioredoxin reductase (TXNRD) activity and changes in mRNA expression levels of antioxidant proteins indicate the activation of cellular defense mechanisms. However, in txnrd-1 deletion mutants, no protective effects of the Se species are observed anymore, which is also reflected by differential gene expression data. ConclusionSe species protect against chemically-induced reactive species formation. The identified immediate and sustained systemic effects of Se species give rise to speculations on possible benefits facing subsequent periods of inadequate Se intake.
Small selenium (Se) species play a major role in the metabolism, excretion and dietary supply of the essential trace element selenium. Human cells provide a valuable tool for investigating currently unresolved issues on the cellular mechanisms of Se toxicity and metabolism. In this study, we developed two isotope dilution inductively coupled plasma tandem-mass spectrometry based methods and applied them to human hepatoma cells (HepG2) in order to quantitatively elucidate total cellular Se concentrations and cellular Se species transformations in relation to the cytotoxic effects of four small organic Se species. Species-and incubation time-dependent results were obtained: the two major urinary excretion metabolites trimethylselenonium (TMSe) and methyl-2-acetamido-2-deoxy-1-seleno-beta- D-galactopyranoside (SeSugar 1) were taken up by the HepG2 cells in an unmodified manner and did not considerably contribute to the Se pool. In contrast, Se-methylselenocysteine (MeSeCys) and selenomethionine (SeMet) were taken up in higher amounts, they were largely incorporated by the cells (most likely into proteins) and metabolized to other small Se species. Two new metabolites of MeSeCys, namely gamma-glutamyl-Se-methylselenocysteine and Se-methylselenoglutathione, were identified by means of HPLC-electrospray-ionization-Orbitrap-MS. They are certainly involved in the (de-) toxification modes of Se metabolism and require further investigation.
Arsenosugars are water-soluble arsenic species predominant in marine algae and other seafood including mussels and oysters. They typically occur at levels ranging from 2 to 50 mg arsenic/kg dry weight. Most of the arsenosugars contain arsenic as a dimethylarsinoyl group (Me2As(O)-), commonly referred to as the oxo forms, but thio analogues have also been identified in marine organisms and as metabolic products of oxo-arsenosugars. So far, no data regarding toxicity and toxicokinetics of thio-arsenosugars are available. This in vitro-based study indicates that thio-dimethylarsenosugar-glycerol exerts neither pronounced cytotoxicity nor genotoxicity even though this arsenical was bioavailable to human hepatic (HepG2) and urothelial (UROtsa) cells. Experiments with the Caco-2 intestinal barrier model mimicking human absorption indicate for the thio-arsenosugar-glycerol higher intestinal bioavailability as compared to the oxo-arsenosugars. Nevertheless, absorption estimates were much lower in comparison to other arsenicals including arsenite and arsenic-containing hydrocarbons. Arsenic speciation in cell lysates revealed that HepG2 cells are able to metabolise the thio-arsenosugar-glycerol to some extent to dimethylarsinic acid (DMA). These first in vitro data cannot fully exclude risks to human health related to the presence of thio-arsenosugars in food. (C) 2016 Elsevier GmbH. All rights reserved.